Zobrazeno 1 - 10
of 29
pro vyhledávání: '"J.R. Lorenzo-González"'
Autor:
A. Pato Pato, E. Costa Arpín, A. Rodríguez Regal, I. Rodríguez Constenla, I. Cimas Hernando, I. Muñoz Pousa, L. Naya Ríos, J.R. Lorenzo González, M.C. Amigo Jorrín, J.M. Prieto González
Publikováno v:
Neurología (English Edition), Vol 36, Iss 5, Pp 346-352 (2021)
Introduction: The safety and effectiveness of natalizumab in patients with relapsing-remitting multiple sclerosis (RRMS) has been demonstrated in clinical trials. However, due to the limitations of these trials, it is important to know how the condit
Externí odkaz:
https://doaj.org/article/d53d1dc013244c6c9e4b739b904e8dea
Autor:
J.R. Lorenzo González, E Costa Arpín, I. Muñoz Pousa, A Rodríguez Regal, I. Cimas Hernando, A. Pato Pato, M.C. Amigo Jorrín, I. Rodríguez Constenla, L. Naya Ríos, J.M. Prieto González
Publikováno v:
Neurología. 36:346-352
Resumen Introduccion La efectividad y seguridad de natalizumab en pacientes con esclerosis multiple remitente recurrente (EMRR) se demostro en ensayos clinicos. Sin embargo, por las limitaciones de estos es importante saber como se comporta en condic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2886afc0b321c990f3ad2864fed1f1c
https://doi.org/10.1016/j.nrl.2018.02.003
https://doi.org/10.1016/j.nrl.2018.02.003
Autor:
M.C. Amigo Jorrín, J.M. Prieto González, I. Cimas Hernando, L. Naya Ríos, A Rodríguez Regal, I. Rodríguez Constenla, A. Pato Pato, J.R. Lorenzo González, I. Muñoz Pousa, E Costa Arpín
Publikováno v:
Neurología (English Edition), Vol 36, Iss 5, Pp 346-352 (2021)
Introduction: The safety and effectiveness of natalizumab in patients with relapsing-remitting multiple sclerosis (RRMS) has been demonstrated in clinical trials. However, due to the limitations of these trials, it is important to know how the condit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a33824bcbb9b6e19b23823f24d7955c
http://www.sciencedirect.com/science/article/pii/S2173580820300055
http://www.sciencedirect.com/science/article/pii/S2173580820300055
Autor:
A. Pato Pato, E. Cebrián Pérez, I. Cimas Hernando, J.R. Lorenzo González, I. Rodríguez Constenla, F. Gude Sampedro
Publikováno v:
Neurología, Vol 26, Iss 1, Pp 32-38 (2011)
Resumen: Introducción: Se ha realizado una estimación económica de los costes de epilepsia en adultos. Métodos: Estudio observacional prospectivo realizado durante 6 meses, en pacientes epilépticos mayores de 14 años. Se excluyeron los paciente
Externí odkaz:
https://doaj.org/article/3d6f7c30b3a4476996c18083926dfafd
Autor:
A. Pato Pato, E. Cebrián Pérez, I. Cimas Hernando, J.R. Lorenzo González, I. Rodríguez Constenla, F. Gude Sampedro
Publikováno v:
Neurología (English Edition), Vol 26, Iss 1, Pp 32-38 (2011)
Introduction: A financial estimate has been made of the costs of epilepsy in adults. Methods: A prospective, observational study, over a period of 6 months, on epileptic patients over 14 years old. Patients with concomitant diseases that could influe
Externí odkaz:
https://doaj.org/article/03f565244e6d433f935a028cf6760442
Autor:
F. Gude Sampedro, A. Pato Pato, I. Rodríguez Constenla, J.R. Lorenzo González, I. Cimas Hernando, E. Cebrián Pérez
Publikováno v:
Neurología (English Edition), Vol 26, Iss 1, Pp 32-38 (2011)
Introduction: A financial estimate has been made of the costs of epilepsy in adults. Methods: A prospective, observational study, over a period of 6 months, on epileptic patients over 14 years old. Patients with concomitant diseases that could influe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6f221be49a41857b744001a42a8ca95
Autor:
E. Santos Armentia, I. Requena Caballero, J.R. Lorenzo González, M. López Fernández, I. Cimas Hernando, I. Rodríguez Constenla, A. Pato Pato
Publikováno v:
Revista Clínica Española. 214:e29-e31
Descrita por primera vez en el ano 2010, la inflamacion linfocitica cronica con realce pontino perivascular y respuesta a esteroides (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids [CLIPPERS]) es una ent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e7ec81cca9c99bd5c7704b81b3725ff
https://doi.org/10.1016/j.rce.2013.12.015
https://doi.org/10.1016/j.rce.2013.12.015
Autor:
M.L. Aguado-Valcárcel, Ana Rodriguez-Regal, Llaneza-González, D. Escriche-Jaime, Alfredo Puy-Núñez, J.R. Lorenzo-González, D.A. García-Estévez, M.J. Moreno-Carretero, M.C. Amigo-Jorrín, Eva Costa-Arpin, M. Rodríguez-Rodríguez, A. López-Real, J.M. Prieto, D. Muñoz, Luciana Midaglia, Pato-Pato A
Publikováno v:
Revista de Neurología. 63:13
Introduction. The effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis (RRMS) have been proven in clinical trials. Yet,due to their limitations,it is important to know how it behaves under everyday clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0130cceb5bd713500e596d001fc1b4a
https://doi.org/10.33588/rn.63s01.2016255
https://doi.org/10.33588/rn.63s01.2016255
Publikováno v:
Neurología (English Edition). 25(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59eae1d602575f5ae2cc0cb16760f771
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.